Castleman Disease Trial, Recruiting NCT02817997 Sponsor: University of Pennsylvania Condition: Castleman Disease
Back to Castleman Disease

Castleman Disease Trial, Recruiting

NCT02817997
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

  • People of any age may be eligible to join.
  • You must have a pathology report (a lab report from a tissue sample) that suggests a diagnosis of Castleman disease, and this report must be able to be uploaded electronically — the disease must not be limited to the skin only.
  • You must be able to give your consent electronically, following the rules in your local area.
  • Deceased patients may also be enrolled if a pathology report suggesting Castleman disease can be provided or located by the research team.

Who may not be able to join:

  • There are no specific exclusion criteria for this registry — the trial is intentionally open to as wide a range of participants as possible.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joshua Brandstadter, MD, PhD, MSc, University of Pennsylvania

Phone: 267-847-8220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2016
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Common Symptoms; Common Laboratory Abnormalities; Treatment; Survival; Identify patient subtypes; Identify clinical outcome measures; Identify clinical biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov